{"id":"https://openalex.org/W2002392492","doi":"https://doi.org/10.1016/j.jval.2013.08.366","title":"Resource Consumption Evaluation Associated with Rituximab Administration in Portugal","display_name":"Resource Consumption Evaluation Associated with Rituximab Administration in Portugal","alternate_titles":[],"publication_year":2013,"publication_date":"2013-10-22","ids":{"openalex":"https://openalex.org/W2002392492","doi":"https://doi.org/10.1016/j.jval.2013.08.366","mag":"2002392492"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2013.08.366","doi":"https://doi.org/10.1016/j.jval.2013.08.366","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.08.366","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002392492"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2013.08.366","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091098373","display_name":"Catarina S. Pereira","orcid":"https://orcid.org/0000-0002-8437-7432","observed_orcids":["https://orcid.org/0000-0002-8437-7432"]},"institutions":[{"id":"https://openalex.org/I4210145431","display_name":"Roche (Portugal)","ror":"https://ror.org/04zt79h83","country_code":"PT","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210145431"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"C. Pereira","raw_affiliation_strings":["Roche Farmac\u00eautica Qu\u00edmica, Lda., Amadora, Portugal","Roche Farmac\u00eautica Quimica, Lda., Amadora, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Farmac\u00eautica Qu\u00edmica, Lda., Amadora, Portugal","institution_ids":["https://openalex.org/I4210145431"]},{"raw_affiliation_string":"Roche Farmac\u00eautica Quimica, Lda., Amadora, Portugal","institution_ids":["https://openalex.org/I4210145431"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023265728","display_name":"Andrea Santos","orcid":"https://orcid.org/0000-0001-9931-8446","observed_orcids":["https://orcid.org/0000-0001-9931-8446"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Santos","raw_affiliation_strings":["Prime Focus Health, Pa\u00e7o de Arcos, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prime Focus Health, Pa\u00e7o de Arcos, Portugal","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"16","issue":"7","first_page":"A386","last_page":"A386"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.51419997215271,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.51419997215271,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.3425000011920929,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0357000008225441,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.7609999775886536},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.7799999713897705},{"id":"https://openalex.org/keywords/follicular-non-hodgkin-lymphoma","display_name":"follicular non-Hodgkin lymphoma","score":0.9419999718666077},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.5410000085830688},{"id":"https://openalex.org/keywords/hospital-efficiency","display_name":"hospital efficiency","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9174120426177979},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8463078737258911},{"id":"https://openalex.org/C2777480716","wikidata":"https://www.wikidata.org/wiki/Q23582796","display_name":"Resource consumption","level":2,"score":0.4619821012020111},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3642493486404419},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3041296899318695},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2013.08.366","doi":"https://doi.org/10.1016/j.jval.2013.08.366","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.08.366","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2013.08.366","doi":"https://doi.org/10.1016/j.jval.2013.08.366","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.08.366","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2074831318","https://openalex.org/W2980141953","https://openalex.org/W2741186435","https://openalex.org/W2472310215","https://openalex.org/W2083899772","https://openalex.org/W2154606293","https://openalex.org/W4390125988","https://openalex.org/W2402579232","https://openalex.org/W2505166698","https://openalex.org/W3029854097"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002392492","counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
